https://www.selleckchem.com/pr....oducts/Everolimus(RA
Target dose coverage was achieved in 14/30 (47%) FS-HDR-BT plans and 17/30 (57%) MR-Linac plans, with comparable median D95% and D90%. In FS-HDR-BT plans, a larger volume reached≥ 150% of the prescribed dose. Urethra D10%, rectum D1cm , and rectum D2cm were lower in the FS-HDR-BT plans, while bladder dose was comparable for both modalities. Single fraction treatment of recurrent prostate cancer lesions may be feasible using stereotactic body radiotherapy (SBRT) on a MR-Linac system. Single fraction treatment of recurrent pros